Evidence map›Paper›PMID 27335088›Full record

Trial reportIntegrative cancer therapies2017

A Feasibility Study of Moxibustion for Treating Anorexia and Improving Quality of Life in Patients With Metastatic Cancer: A Randomized Sham-Controlled Trial.

Ju-Hyun Jeon, Chong-Kwan Cho, So-Jung Park, Hwi-Joong Kang, Kyungmin Kim, In-Chul Jung, Young-Il Kim, Suk-Hoon Lee, Hwa-Seung Yoo

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Integrative cancer therapies, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 2 pooled it
5.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 2 syntheses or guidelines pooled it, 29 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Analysis of Acupoints Combination for Cancer-Related Anorexia Based on Association Rule Mining.Evidence-based complementary and alternative medicine : eCAM · 2022
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Ju-Hyun Jeon1 Daejeon Korean Medicine Hospital of Daejeon University, Daejeon, Republic of Korea.
Chong-Kwan Cho2 Dunsan Korean Medicine Hospital of Daejeon University, Daejoen, Republic of Korea.
So-Jung Park2 Dunsan Korean Medicine Hospital of Daejeon University, Daejoen, Republic of Korea.
Hwi-Joong Kang2 Dunsan Korean Medicine Hospital of Daejeon University, Daejoen, Republic of Korea.
Kyungmin Kim1 Daejeon Korean Medicine Hospital of Daejeon University, Daejeon, Republic of Korea.
In-Chul Jung2 Dunsan Korean Medicine Hospital of Daejeon University, Daejoen, Republic of Korea.
Young-Il Kim2 Dunsan Korean Medicine Hospital of Daejeon University, Daejoen, Republic of Korea.
Suk-Hoon Lee3 Chungnam National University, Daejeon, Republic of Korea.
Hwa-Seung Yoo2 Dunsan Korean Medicine Hospital of Daejeon University, Daejoen, Republic of Korea.
Dunsan Korean Medicine Hospital · KRDaejeon University · KRChungnam National University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe aim of this study was to determine the feasibility, acceptability, and safety of using moxibustion for treating anorexia and improving quality of life in patients with metastatic cancer.

methodsWe conducted a randomized sham-controlled trial of moxibustion. Sixteen patients with metastatic cancer were recruited from Daejeon, South Korea. The patients were randomly placed into a true or a sham moxibustion group and received 10 true or sham moxibustion treatments administered to the abdomen (CV12, CV8, CV4) and legs (ST36) over a 2-week period. Outcome measures included interest in participating in the trial, identification of successful recruitment strategies, the appropriateness of eligibility criteria, and compliance with the treatment plan (ie, attendance at treatment sessions). Clinical outcomes included results of the Functional Assessment of Anorexia/Cachexia Therapy (FAACT), answers on the European Organization for Research and Treatment of Cancer 30-item core quality of life (EORTC QLQ-C30) questionnaires, scores on the visual analogue scale (VAS), and the results from blood tests and a safety evaluation.

resultsMoxibustion was an acceptable intervention in patients with metastatic cancer. Compliance with the treatment protocol was high, with 11 patients completing all 10 treatments. No serious adverse events related to moxibustion occurred, but 4 patients in the true moxibustion group reported mild rubefaction, which disappeared in a few hours.

conclusionThis study suggests that moxibustion may be safely used to treat anorexia and improve quality of life in patients with metastatic cancer. However, further research is needed to confirm this result.

Indexed as

AnorexiaFeasibility StudiesFemaleHumansMaleMiddle AgedMoxibustionNeoplasm MetastasisNeoplasmsQuality of LifeRepublic of Koreaanorexiafeasibility studymetastatic cancermoxibustionquality of life

Identifiers

PMID27335088
PMCPMC5736070
OpenAlexW2474264471

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.